Mito-Bomb : Targeting Mitochondria for Cancer Therapy
© 2021 Wiley-VCH GmbH.
Publié dans: | Advanced materials (Deerfield Beach, Fla.). - 1998. - 33(2021), 43 vom: 30. Okt., Seite e2007778 |
---|---|
Auteur principal: | |
Autres auteurs: | , , , , , , , , |
Format: | Article en ligne |
Langue: | English |
Publié: |
2021
|
Accès à la collection: | Advanced materials (Deerfield Beach, Fla.) |
Sujets: | Journal Article Review cancer therapy chemodynamic therapy mitochondria photodynamic therapy photothermal therapy Antineoplastic Agents |
Résumé: | © 2021 Wiley-VCH GmbH. Cancer has been one of the most common life-threatening diseases for a long time. Traditional cancer therapies such as surgery, chemotherapy (CT), and radiotherapy (RT) have limited effects due to drug resistance, unsatisfactory treatment efficiency, and side effects. In recent years, photodynamic therapy (PDT), photothermal therapy (PTT), and chemodynamic therapy (CDT) have been utilized for cancer treatment owing to their high selectivity, minor resistance, and minimal toxicity. Accumulating evidence has demonstrated that selective delivery of drugs to specific subcellular organelles can significantly enhance the efficiency of cancer therapy. Mitochondria-targeting therapeutic strategies are promising for cancer therapy, which is attributed to the essential role of mitochondria in the regulation of cancer cell apoptosis, metabolism, and more vulnerable to hyperthermia and oxidative damage. Herein, the rational design, functionalization, and applications of diverse mitochondria-targeting units, involving organic phosphine/sulfur salts, quaternary ammonium (QA) salts, peptides, transition-metal complexes, guanidinium or bisguanidinium, as well as mitochondria-targeting cancer therapies including PDT, PTT, CDT, and others are summarized. This review aims to furnish researchers with deep insights and hints in the design and applications of novel mitochondria-targeting agents for cancer therapy |
---|---|
Description: | Date Completed 24.07.2024 Date Revised 27.08.2024 published: Print-Electronic Citation Status MEDLINE |
ISSN: | 1521-4095 |
DOI: | 10.1002/adma.202007778 |